Vanguard Group’s TransCode Therapeutics RNAZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-200,117
| Closed | -$220K | – | 4549 |
|
|
2022
Q3 | $220K | Hold |
200,117
| – | – | ﹤0.01% | 4400 |
|
|
2022
Q2 | $252K | Hold |
200,117
| – | – | ﹤0.01% | 4437 |
|
|
2022
Q1 | $576K | Hold |
200,117
| – | – | ﹤0.01% | 4365 |
|
|
2021
Q4 | $508K | Hold |
200,117
| – | – | ﹤0.01% | 4430 |
|
|
2021
Q3 | $598K | Buy |
+200,117
| New | +$598K | ﹤0.01% | 4356 |
|